NuCana PLC (NCNA)

NASDAQ HEALTHCARE
$2.06 -4.19% RSI 50 Neutral Add Alert

Moving Averages

SMA 200
$4.49
Price below

Company Profile

NuCana plc, a clinical-stage biopharmaceutical company, is dedicated to the development of products for the treatment of cancer. The company is headquartered in Edinburgh, the United Kingdom.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$8.20M
Beta
1.799
Dividend Yield
0.00%
52-Week High
$250
52-Week Low
$1.33

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 57.0
VRTX
Vertex Pharmaceuticals Inc
RSI 41.0
CRSP
CRISPR Therapeutics AG
RSI 50.0
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 50.0
MRNA
Moderna Inc
RSI 36.0
VKTX
Viking Therapeutics Inc
RSI 38.0

Data last updated: April 11, 2026 at 5:23 PM EDT

Track NCNA for free

Get e-mail RSI alerts when NuCana PLC enters oversold or overbought territory. Free forever.

Add Alert